External beam radiotherapy with or without androgen deprivation therapy in elderly patients with high metastatic risk prostate cancer

Our findings failed to confirm that combination of ADT at RT reduces CSM rates in high metastatic risk PCa patients aged 80 years or more. Moreover, combination of ADT at RT resulted in a significant cost increase, relative to RT alone.